Number of randomized patients:
103
Number of recruiting sites:
22
Key inclusion criteria
- Informed consent as documented by signature
- Age ≥ 18 to < 86 years
- Acute ischemic stroke (AIS)
- NIHSS ≥ 8 and < 30
- Patient is eligible for IV t-PA
- Patient is eligible for endovascular therapy
- Randomization no later than 4 hours 15 minutes after stroke symptom onset and initiation of IV t-PA must be started within 4 hours 30 minutes of stroke symptoms onset
- Occlusion (TICI 0-1) of the intracranial internal carotid artery (ICA) , M1 segment of the middle cerebral artery (MCA), or both confirmed by CT or MR angiography, accessible for MT
- ASPECTS score greater ≥ 6
Key exclusion criteria
- Acute intracranial hemorrhage
- Any contraindication for IV t-PA
- Pre-treatment with IV t-PA
- In-hospital stroke
- Pregnancy or lactating women
- Known (serious) sensitivity to radiographic contrast agents, nickel, titanium metals or their alloys
- Current participation in a clinical trial
- Renal insufficiency
- Life expectancy less than 90 days at baseline
- Known advanced dementia or significant pre-stroke disability (mRS score of ≥ 2)